Osteonecrosis of the Jaws in Patients Receiving Anti-Angiogenic Drugs and Chemotherapeutics: Literature Review and Case Reports
Medication-related osteonecrosis of the jaw (MRONJ) is a relatively rare but serious pathology associated with the use of bisphosphonates (BPs) and antiresorptive drugs in patients with bone metastases, multiple myeloma and osteoporosis. Various cases of patients with jaw bone necrosis due to BPs ha...
Guardado en:
Autores principales: | Mihaylova Z., Ugrinov R., Aleksiev E., Stanimirov P. |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/107e0ef6c84540ddbe2f2576f9014dfa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Matrix-Bound Zolzoledronate Enhances the Biofilm Colonization of Hydroxyapatite: Effects on Osteonecrosis
por: Ranya Elsayed, et al.
Publicado: (2021) -
Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study
por: Qi Zheng, et al.
Publicado: (2021) -
Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
por: Pan WL, et al.
Publicado: (2017) -
Anti-Angiogenic Agent Combined with Anti-PD-1 Immunotherapy Showed Activity in Patients With Classical Hodgkin Lymphoma Who Have Failed Immunotherapy: A Retrospective Case Report Study
por: Zheng Yan, et al.
Publicado: (2021) -
Small Extracellular Vesicles Derived from Adipose Tissue Prevent Bisphosphonate-Related Osteonecrosis of the Jaw by Promoting Angiogenesis
por: Huang J, et al.
Publicado: (2021)